Skip to main navigation

Top Menu

  • Expanded Access Program (EAP)
  • News & Events
  • Clinical Trials
  • Contact Us
Catalystpharma.com

Corporate Menu

  • About Catalyst
    • History
    • Management
    • Board Of Directors
  • Patient Focus
    • Patient Stories
      • LEMS Stories
      • CMS Stories
    • Disease Information
      • LEMS
      • CMS
      • MuSK-MG
      • SMA
      • Infantile Spasms
    • Patient Resources
  • Research & Pipeline
    • Roadmap To Success
    • Pipeline (clinical)
      • LEMS Clinical
      • CMS Clinical
      • MuSK-MG Clinical
      • SMA Clinical
      • Infantile Spasms Clinical
    • Amifampridine Phosphate
    • GABA-AT Inhibitors (CPP109 & CPP115)
    • Business Development
    • Professional Outreach
    • Scientific Advisory Board
  • Responsibility
    • Corporate Giving
    • Investigator Sponsored Research
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Board of Directors
      • Management
      • Committee Composition
      • Contact the Board
    • Stockholder Rights Plan
    • Financials
      • SEC Filings
      • Annual Report and Proxy
      • Key Ratios
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Contact Us
Select Page
Stock Information

Mobile Menu

  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Board of Directors
    • Management
    • Committee Composition
    • Contact the Board
  • Stockholder Rights Plan
  • Financials
    • SEC Filings
    • Annual Report and Proxy
    • Key Ratios
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Contact Us

Stock Information

Stock Quote

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low

Stock Chart

Copyright West LLC. Minimum 15 minutes delayed.

Toolkit

  • Email Alerts

  • RSS

  • Print page

  • Search

Footer Menu

  • ABOUT CATALYST
  • PATIENT FOCUS
  • RESPONSIBILITY
  • RESEARCH & PIPELINE
  • EXPANDED ACCESS PROGRAM (EAP)
  • NEWS & EVENTS
  • CONTACT US
  • CLINICAL TRIALS
CONTACT
(305) 420-3200
Email Us
© 2018 Catalyst Pharma | Privacy Policy